Epithelial Displacement Into the Lymphovascular Space Can Be Seen in Breast Core Needle Biopsy Specimens

Dept of Pathology, Seoul National University Bundang Hospital, 166 Gumi-ro, Bundang-gu, Seongnam, Gyeonggi-do, South Korea, 463-707.
American Journal of Clinical Pathology (Impact Factor: 2.51). 05/2010; 133(5):781-7. DOI: 10.1309/AJCPQ0LEIOUTMSUD
Source: PubMed


Breast core needle biopsy (BCNB) has been reported to cause mechanical epithelial displacement into adjacent tissues, leading to diagnostic difficulties. However, epithelial displacement into lymphovascular spaces (EDLS), mimicking true lymphovascular invasion, may also be seen in the initial BCNB specimen itself. We retrospectively reviewed 218 BCNB specimens diagnosed as ductal carcinoma in situ (DCIS) and searched for the presence of EDLS. The subsequent surgically resected specimens for all cases were also reviewed. EDLS was demonstrated in 7 (3.2%) of 218 initial BCNB specimens. It could be differentiated from detached clusters of DCIS cells within preexisting ducts by morphologic features and immunohistochemical stains for D2-40 and p63. EDLS can occur at initial BCNB, and, therefore, the presence of tumor cell clusters within lymphovascular spaces in a BCNB specimen with DCIS may not represent true lymphovascular invasion.

Download full-text


Available from: Ja Seung Koo,
  • [Show abstract] [Hide abstract]
    ABSTRACT: This article discusses the most common small glandular proliferations, namely sclerosing lesions (sclerosing adenosis and radial scar), tubular carcinoma, and epithelial displacement after needle core biopsy, as well as less common entities, such as low-grade adenosquamous carcinoma, microglandular adenosis, and syringomatous adenoma. Due to significant morphologic overlap, these entities are easily mistaken for one another. The similarities and differences among these lesions in their clinicopathologic features, radiologic findings, and immunohistochemical profiles are emphasizesd.
    Surgical Pathology Clinics 09/2012; 5(3):591–643. DOI:10.1016/j.path.2012.06.007
  • [Show abstract] [Hide abstract]
    ABSTRACT: Screening mammography improved early detection of breast cancer and since then, the percentage of patients with node involvement is declining. Sentinel lymph node biopsy (SLNB), although helpful in the diagnostic armamentarium of these patients, has consequential limitations. In these patients, moreover, lymphatic invasion (LI) is of utmost importance to determine the risk of local recurrence. To find an adjuvant histologic approach to assist in pre-operative analysis of the patient's risk for having LI and thus sentinel ± non-sentinel axillary lymph node metastasis, one hundred and twenty patients with early invasive duct carcinoma without axillary lymph node metastasis were evaluated. Logistic regression predictive models were built from 80 patients and validated in the remaining 40 patients. The final stepwise multi-regression analysis identified four sensitive models. In the validation group, model 1 [applicable to tumors grade 3 having micropapillary differentiation (MPD)] correctly identified 92.31% of patients with LI and confirmed LI [positive predictive value (PPV) = 83%], but with moderate sensitivity. Model 2 [applicable to tumors without MPD], model 3 [applicable to tumors grade 1/2], and model 4 [applicable to tumors grade 1/2 having no MPD] all had moderate PPV and a high negative predictive value (NPV) rendering these models reliable negative tests. However, as they had high sensitivity, positive results confirm the presence of LI. Patient with tumors grade 3 and MPD might need SLNB and/or axillary lymph node dissection (ALND). Patients having tumors grade 1/2, size <2 cm, and no MPD nor extensive retraction artifact, SLNB and/or ALND could be omitted. In tumors grade 1/2 (model 2) and those without MPD (model 3), the proposed models are reliable negative tests rather than a definitive positive one.
    Apmis 04/2014; 122(10). DOI:10.1111/apm.12256 · 2.04 Impact Factor